| The association between age of onset of type 2 diabetes and the long-term risk of end-stage kidney disease: a national registry study JI Morton, D Liew, SP McDonald, JE Shaw, DJ Magliano Diabetes Care 43 (8), 1788-1795, 2020 | 61 | 2020 |
| Trends in the incidence of hospitalization for major diabetes-related complications in people with type 1 and type 2 diabetes in Australia, 2010–2019 JI Morton, PA Lazzarini, JE Shaw, DJ Magliano Diabetes Care 45 (4), 789-797, 2022 | 54 | 2022 |
| Lifetime risk, life expectancy, and years of life lost to type 2 diabetes in 23 high-income jurisdictions: a multinational, population-based study D Tomic, JI Morton, L Chen, A Salim, EW Gregg, ME Pavkov, M Arffman, ... The Lancet Diabetes & Endocrinology 10 (11), 795-803, 2022 | 48 | 2022 |
| Mortality trends in type 1 diabetes: a multicountry analysis of six population-based cohorts PLD Ruiz, L Chen, JI Morton, A Salim, B Carstensen, EW Gregg, ... Diabetologia 65 (6), 964-972, 2022 | 48 | 2022 |
| Global trends in the incidence of hospital admissions for diabetes-related foot disease and amputations: a review of national rates in the 21st century PA Lazzarini, SM Cramb, J Golledge, JI Morton, DJ Magliano, ... Diabetologia 66 (2), 267-287, 2023 | 45 | 2023 |
| The association of socioeconomic disadvantage and remoteness with receipt of type 2 diabetes medications in Australia: a nationwide registry study JI Morton, J Ilomӓki, DJ Magliano, JE Shaw Diabetologia 64 (2), 349-360, 2021 | 35 | 2021 |
| The association of attained age, age at diagnosis, and duration of type 2 diabetes with the long-term risk for major diabetes-related complications JI Morton, PA Lazzarini, KR Polkinghorne, B Carstensen, DJ Magliano, ... Diabetes Research and Clinical Practice 190, 110022, 2022 | 23 | 2022 |
| Projecting the incidence and costs of major cardiovascular and kidney complications of type 2 diabetes with widespread SGLT2i and GLP-1 RA use: a cost-effectiveness analysis JI Morton, C Marquina, JE Shaw, D Liew, KR Polkinghorne, Z Ademi, ... Diabetologia 66 (4), 642-656, 2023 | 22 | 2023 |
| Projecting the incidence of type 2 diabetes–related end-stage kidney disease until 2040: a comparison between the effects of diabetes prevention and the effects of diabetes … JI Morton, SP McDonald, A Salim, D Liew, JE Shaw, DJ Magliano Diabetes Care 44 (7), 1515-1523, 2021 | 18 | 2021 |
| Rate of decline in kidney function and known age-of-onset or duration of type 2 diabetes O Buyadaa, A Salim, JI Morton, DJ Magliano, JE Shaw Scientific Reports 11 (1), 14705, 2021 | 16 | 2021 |
| Long-term cost-effectiveness of implementing a lifestyle intervention during pregnancy to reduce the incidence of gestational diabetes and type 2 diabetes M Lloyd, J Morton, H Teede, C Marquina, D Abushanab, DJ Magliano, ... Diabetologia 66 (7), 1223-1234, 2023 | 13 | 2023 |
| Trends in diabetes-related foot disease hospitalizations and amputations in Australia, 2010 to 2019 M Quigley, JI Morton, PA Lazzarini, S Zoungas, JE Shaw, DJ Magliano Diabetes Research and Clinical Practice 194, 110189, 2022 | 13 | 2022 |
| Persistent disparities in diabetes medication receipt by socio‐economic disadvantage in Australia JI Morton, J Ilomӓki, DJ Magliano, JE Shaw Diabetic Medicine 39 (9), e14898, 2022 | 13 | 2022 |
| Lipid-lowering strategies for primary prevention of coronary heart disease in the UK: a cost-effectiveness analysis JI Morton, C Marquina, M Lloyd, GF Watts, S Zoungas, D Liew, Z Ademi Pharmacoeconomics 42 (1), 91-107, 2024 | 12 | 2024 |
| One-year readmission and mortality following ischaemic stroke by diabetes status, sex, and socioeconomic disadvantage: an analysis of 27,802 strokes from 2012 to 2017 JI Morton, J Ilomäki, SJ Wood, JS Bell, JE Shaw, DJ Magliano Journal of the Neurological Sciences 434, 120149, 2022 | 12 | 2022 |
| Projected new-onset cardiovascular disease by socioeconomic group in Australia K Hastings, C Marquina, J Morton, D Abushanab, D Berkovic, S Talic, ... Pharmacoeconomics, 1-12, 2022 | 11 | 2022 |
| Projecting the health and economic burden of cardiovascular disease among people with type 2 diabetes, 2022–2031 D Abushanab, C Marquina, JI Morton, D Al-Badriyeh, M Lloyd, ... Pharmacoeconomics 41 (6), 719-732, 2023 | 10 | 2023 |
| Treatment gaps, 1-year readmission and mortality following myocardial infarction by diabetes status, sex and socioeconomic disadvantage JI Morton, J Ilomäki, SJ Wood, JS Bell, Q Huynh, DJ Magliano, JE Shaw J Epidemiol Community Health 76 (7), 637-645, 2022 | 9 | 2022 |
| Cost-Effectiveness of Screening Strategies for Familial Hypercholesterolaemia: An Updated Systematic Review C Marquina, JI Morton, M Lloyd, D Abushanab, Y Baek, T Abebe, A Livori, ... PharmacoEconomics 42 (4), 373-392, 2024 | 8 | 2024 |
| Reasons for hospitalisation in Australians with type 2 diabetes compared to the general population, 2010–2017 D Tomic, A Salim, JI Morton, DJ Magliano, JE Shaw Diabetes Research and Clinical Practice 194, 110143, 2022 | 8 | 2022 |
Dianna J MaglianoMonash universityE-mail megerősítve itt: monash.edu